Cellular/Molecular
The Human Immunodeficiency Virus-1 Protein Tat and Its Discrete Fragments Evoke Selective Release of Acetylcholine from Human and Rat Cerebrocortical Terminals through Species-Specific Mechanisms
Marco Feligioni, Luca Raiteri, Roberto Pattarini, Massimo Grilli, Santina Bruzzone, Paolo Cavazzani, Maurizio Raiteri and Anna Pittaluga
Journal of Neuroscience 30 July 2003, 23 (17) 6810-6818; DOI: https://doi.org/10.1523/JNEUROSCI.23-17-06810.2003
Marco Feligioni
1Pharmacology and Toxicology Section, Department of Experimental Medicine,
2Biochemistry Section, Department of Experimental Medicine, and
3Center of Excellence for Biomedical Research, University of Genova, 16148 Genova, Italy,
4Division of Neurovirology, University of Manitoba, Manitoba, Canada R3T 2N2, and
5Division of Neurosurgery, Galliera Hospital, 16128 Genova, Italy
Luca Raiteri
1Pharmacology and Toxicology Section, Department of Experimental Medicine,
2Biochemistry Section, Department of Experimental Medicine, and
3Center of Excellence for Biomedical Research, University of Genova, 16148 Genova, Italy,
4Division of Neurovirology, University of Manitoba, Manitoba, Canada R3T 2N2, and
5Division of Neurosurgery, Galliera Hospital, 16128 Genova, Italy
Roberto Pattarini
1Pharmacology and Toxicology Section, Department of Experimental Medicine,
2Biochemistry Section, Department of Experimental Medicine, and
3Center of Excellence for Biomedical Research, University of Genova, 16148 Genova, Italy,
4Division of Neurovirology, University of Manitoba, Manitoba, Canada R3T 2N2, and
5Division of Neurosurgery, Galliera Hospital, 16128 Genova, Italy
Massimo Grilli
1Pharmacology and Toxicology Section, Department of Experimental Medicine,
2Biochemistry Section, Department of Experimental Medicine, and
3Center of Excellence for Biomedical Research, University of Genova, 16148 Genova, Italy,
4Division of Neurovirology, University of Manitoba, Manitoba, Canada R3T 2N2, and
5Division of Neurosurgery, Galliera Hospital, 16128 Genova, Italy
Santina Bruzzone
1Pharmacology and Toxicology Section, Department of Experimental Medicine,
2Biochemistry Section, Department of Experimental Medicine, and
3Center of Excellence for Biomedical Research, University of Genova, 16148 Genova, Italy,
4Division of Neurovirology, University of Manitoba, Manitoba, Canada R3T 2N2, and
5Division of Neurosurgery, Galliera Hospital, 16128 Genova, Italy
Paolo Cavazzani
1Pharmacology and Toxicology Section, Department of Experimental Medicine,
2Biochemistry Section, Department of Experimental Medicine, and
3Center of Excellence for Biomedical Research, University of Genova, 16148 Genova, Italy,
4Division of Neurovirology, University of Manitoba, Manitoba, Canada R3T 2N2, and
5Division of Neurosurgery, Galliera Hospital, 16128 Genova, Italy
Maurizio Raiteri
1Pharmacology and Toxicology Section, Department of Experimental Medicine,
2Biochemistry Section, Department of Experimental Medicine, and
3Center of Excellence for Biomedical Research, University of Genova, 16148 Genova, Italy,
4Division of Neurovirology, University of Manitoba, Manitoba, Canada R3T 2N2, and
5Division of Neurosurgery, Galliera Hospital, 16128 Genova, Italy
Anna Pittaluga
1Pharmacology and Toxicology Section, Department of Experimental Medicine,
2Biochemistry Section, Department of Experimental Medicine, and
3Center of Excellence for Biomedical Research, University of Genova, 16148 Genova, Italy,
4Division of Neurovirology, University of Manitoba, Manitoba, Canada R3T 2N2, and
5Division of Neurosurgery, Galliera Hospital, 16128 Genova, Italy
Published eLetters
Guidelines
As a forum for professional feedback, submissions of letters are open to all. You do not need to be a subscriber. To avoid redundancy, we urge you to read other people's letters before submitting your own. Name, current appointment, place of work, and email address are required to send a letter, and will be published with your review. We also require that you declare any competing financial interests. Unprofessional submissions will not be considered or responded to.
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Journal of Neuroscience
Vol. 23, Issue 17
30 Jul 2003
The Human Immunodeficiency Virus-1 Protein Tat and Its Discrete Fragments Evoke Selective Release of Acetylcholine from Human and Rat Cerebrocortical Terminals through Species-Specific Mechanisms
Marco Feligioni, Luca Raiteri, Roberto Pattarini, Massimo Grilli, Santina Bruzzone, Paolo Cavazzani, Maurizio Raiteri, Anna Pittaluga
Journal of Neuroscience 30 July 2003, 23 (17) 6810-6818; DOI: 10.1523/JNEUROSCI.23-17-06810.2003
The Human Immunodeficiency Virus-1 Protein Tat and Its Discrete Fragments Evoke Selective Release of Acetylcholine from Human and Rat Cerebrocortical Terminals through Species-Specific Mechanisms
Marco Feligioni, Luca Raiteri, Roberto Pattarini, Massimo Grilli, Santina Bruzzone, Paolo Cavazzani, Maurizio Raiteri, Anna Pittaluga
Journal of Neuroscience 30 July 2003, 23 (17) 6810-6818; DOI: 10.1523/JNEUROSCI.23-17-06810.2003
Jump to section
Keywords
Responses to this article
Jump to comment:
No eLetters have been published for this article.